INS and Hyperglycemia: Metabolomics and kinetic studies in unprovoked A−β+ KPD patients also demonstrated significantly decreased endogenous arginine availability in response to hyperglycemia compared to controls with obesity; this was associated with a marked defect in insulin secretion in response to glucose but normal insulin secretion in response to arginine [26].